Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.57 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.57 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.57 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.55 |
| ▸ | CES2 | O00748 | 1/20 | 0.55 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.53 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | FYN | P06241 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30675560 | 1.00 | SMN1; SMN2 (0.58) | SMN1; SMN2ALDH1A1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL4687827 | 0.86 | HTT (0.56) | SMN1; SMN2ALDH1A1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL5726240 | 0.86 | SMN1; SMN2 (0.63) | SMN1; SMN2ALDH1A1MEN1RAB9AKMT2A | |
| SCHEMBL1851780 | 0.85 | SMN1; SMN2 (0.68) | SMN1; SMN2ALDH1A1MEN1RAB9AKMT2A | |
| SCHEMBL30492996 | 0.85 | SMN1; SMN2 (0.68) | SMN1; SMN2ALDH1A1MEN1RAB9AKMT2A | |
| SCHEMBL27295012 | 0.84 | SMN1; SMN2 (0.53) | SMN1; SMN2ALDH1A1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL6381094 | 0.83 | SMN1; SMN2 (0.51) | SMN1; SMN2ALDH1A1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL8348162 | 0.83 | IMPDH2 (0.55) | NOX4SLC22A6SLC22A8MEN1RAB9A | |
| SCHEMBL9817876 | 0.82 | GRM4 (0.58) | SMN1; SMN2ALDH1A1MEN1KMT2AHTT | |
| SCHEMBL8413542 | 0.81 | RORC (0.66) | SMN1; SMN2ALDH1A1MEN1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117202986-A | Hydrogel encapsulation and method for producing same | 国际香精香料公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-116764558-A | Microcapsule compositions stabilized with viscosity control agents | 国际香料和香精公司 | 2023-09-19 | — | — | CN | disclosed |
| EP-3836799-A1 | OBTAINING A VOLATILE FRACTION FROM JUICES OR ALCOHOLIC BEVERAGES | Symrise AG (DE) | 2021-06-23 | — | — | EP | disclosed |
| CN-112566507-A | Obtaining volatile fraction from fruit and vegetable juice or alcoholic beverage | 西姆莱斯有限公司 | 2021-03-26 | — | — | CN | disclosed |
| CN-112041176-A | System and method for printing and drying flavors and fragrances | 国际香料和香精公司 | 2020-12-04 | — | — | CN | disclosed |
| EP-3154967-B1 | PROCESSES FOR MAKING ALKYLATED ARYLPIPERAZINE AND ALKYLATED ARYLPIPERIDINE COMPOUNDS INCLUDING NOVEL INTERMEDIATES | JOHNSON MATTHEY PLC (GB) | 2020-07-29 | — | — | EP | disclosed |
| US-10695272-B2 | Compositions containing microcapsules coated with deposition proteins | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2020-06-30 | — | — | US | disclosed |
| CN-107490640-B | Method capable of simultaneously detecting acetaminophen and 8 plasma metabolites thereof | 华润三九（枣庄）药业有限公司 | 2020-06-12 | — | — | CN | disclosed |
| WO-2020035147-A1 | OBTAINING A VOLATILE FRACTION FROM JUICES OR ALCOHOLIC BEVERAGES | SYMRISE AG (DE) | 2020-02-20 | — | — | WO | disclosed |
| US-20180250204-A1 | COMPOSITIONS CONTAINING MICROCAPSULES COATED WITH DEPOSITION PROTEINS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2018-09-06 | — | — | US | disclosed |
| US-20080242740-A1 | AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS | SYMRISE GMBH & CO. KG (DE) | 2008-10-02 | — | — | US | disclosed |
| US-20050234132-A1 | Production of cis-pellitorin and use as a flavouring | SYMRISE AG (DE) | 2005-10-20 | — | — | US | disclosed |
| US-20040241312-A1 | Use of 2E,4E-decadienoic acid isobutylamide for imparting a salivation inducing effect to a foodstuff, an oral hygiene preparation or a gourmet or snack preparation; preparation by amidating a dodecadienoate with isobutylamine | SYMRISE AG (DE) | 2004-12-02 | — | — | US | disclosed |
| CN-1181376-A | Production of benzophenone derivatives | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1998-05-13 | — | — | CN | disclosed |
| EP-0839801-A2 | Production of benzophenone derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-05-06 | — | — | EP | disclosed |
| US-4413006-A | N-Aryl-N-phenoxy-alkyl-piperazine compounds useful in decreasing intracranial pressure | TANABE SEIYAKU CO., LTD. (JP) | 1983-11-01 | — | — | US | disclosed |
| EP-0034284-B1 | PIPERAZINE DERIVATIVE, PROCESSES FOR PREPARING THE SAME AND THERAPEUTIC COMPOSITIONS CONTAINING IT | Tanabe Seiyaku Co., Ltd. (JP) | 1983-10-05 | — | — | EP | disclosed |
| EP-0034752-B1 | PHENOXYALKANE DERIVATIVE AND PROCESSES FOR PREPARING SAME | Tanabe Seiyaku Co., Ltd. (JP) | 1983-06-08 | — | — | EP | disclosed |
| EP-0034752-A1 | Phenoxyalkane derivative and processes for preparing same | Tanabe Seiyaku Co., Ltd. (JP) | 1981-09-02 | — | — | EP | disclosed |
| EP-0034284-A2 | Piperazine derivative, processes for preparing the same and therapeutic compositions containing it | Tanabe Seiyaku Co., Ltd. (JP) | 1981-08-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234132-A1 | Production of cis-pellitorin and use as a flavouring | NISCH, CYP8B1, DLAT | SMN1; SMN2 4793/4885ALDH1A1 429/4885CSNK2A2 1279/4885 |
| US-10695272-B2 | Compositions containing microcapsules coated with deposition proteins | SAAL1, AUP1, FABP5 | SMN1; SMN2 2186/4885ALDH1A1 4547/4885CSNK2A2 1472/4885 |
| US-20080242740-A1 | AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS | TAS2R5, TAS2R20, TAS2R40 | SMN1; SMN2 4384/4885ALDH1A1 401/4885CSNK2A2 3814/4885 |
| US-20180250204-A1 | COMPOSITIONS CONTAINING MICROCAPSULES COATED WITH DEPOSITION PROTEINS | SAAL1, AUP1, FABP5 | SMN1; SMN2 2186/4885ALDH1A1 4547/4885CSNK2A2 1472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.